Bavisant dihydrochloride

• CAT Number: I005528
• CAS Number: 929622-09-3
• Molecular Formula: C19H29Cl2N3O2
• Molecular Weight: 402.36
• Purity: ≥95%
• Synonyms: (4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone dihydrochloride
• Target: Neuronal Signaling
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IUPAC Name: (4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone;dihydrochloride
• InChI: InChI=1S/C19H27N3O2.2ClH/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20;;/h1-4,18H,5-15H2;2*1H
• InChIKey: PBVFXCXXVLBYKF-UHFFFAOYSA-N
• SMILES: C1CC1N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4.Cl.Cl

Bavisant dihydrochloride（Cat No.:I005528）is a compound under investigation for its potential therapeutic effects as a selective histamine H3 receptor antagonist. By blocking H3 receptors, Bavisant may enhance the release of key neurotransmitters such as acetylcholine, dopamine, and norepinephrine, which are crucial for cognition, attention, and wakefulness. It has been studied primarily for conditions like cognitive impairment, attention disorders, and narcolepsy. Its potential to improve cognitive function and alertness makes it a promising candidate in treating neuropsychiatric disorders, although further research is needed to fully establish its clinical benefits and safety.